HQY
HealthEquityCAI scenario view
RankAlpha Sentiment CodexThe current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
Shares fell after the August 27 results despite the beat and raised guidance; the checked coverage establishes the direction, not a reliable closing-day percentage (MT Newswires). The $88.46 September 30 anchor remains below reported post-print targets, but target revisions are mixed in conviction and a full forward-estimate revision series is unavailable. Sentiment zeros denote unavailable measurements, not neutral observations; no sufficient social coverage was supplied.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
The company reported second-quarter revenue of $350.7 million, up 8%, and a 48% adjusted EBITDA margin, then raised fiscal 2027 guidance to $1.411–$1.421 billion of revenue and $628–$636 million of adjusted EBITDA. Execution through the January 31 fiscal year-end is the key test; that date is not an announced results date [#SEC-8K-2026-08-27] [#10-Q-2026-08-27].
Management scheduled an Investor Day for April 13, 2027. It may clarify longer-term targets, but the stored earnings-call excerpt provides no new targets [#PR-EARNINGS-2026-09-01].
Second-quarter HSAs reached 10.7 million, up 8% year over year; HSA assets rose 14% to $37.9 billion, and new HSAs from sales rose 24%. Sustaining account additions and custodial economics would strengthen the longer-term case; deceleration would weaken it [#SEC-8K-2026-08-27].
Recommendation
No formal recommendation provided.

